News | October 19, 2023
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Subscribe To Our Newsletter & Stay Updated
